Jump to content

Category:Raphael MECHOULAM (deceased)

From WikiTrademarks

Raphael MECHOULAM (deceased)

Executive Summary

Raphael MECHOULAM (deceased) is an inventor who has filed 1 patents. Their primary areas of innovation include ACYCLIC OR CARBOCYCLIC COMPOUNDS (1 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), and they have worked with companies such as Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Raphael MECHOULAM (deceased) Monthly Patent Applications.png

Technology Areas

File:Raphael MECHOULAM (deceased) Top Technology Areas.png

List of Technology Areas

  • C07C43/23 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
  • A61K31/085 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K31/09 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61P19/02 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C07C2602/42 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents

Companies

File:Raphael MECHOULAM (deceased) Top Companies.png

List of Companies

  • Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.: 1 patents

Collaborators

Subcategories

This category has the following 4 subcategories, out of 4 total.

M

R

Cookies help us deliver our services. By using our services, you agree to our use of cookies.